港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

宜明昂科-B

7.000

-0.020-0.28%

成交量：338.76萬

成交額：2,414.56萬

市值：28.49億

市盈率：-7.72

高：7.370

開：7.300

低：6.910

收：7.020

資料載入中...

總覽公司新聞公告

醫藥股多數走高來凱醫藥(02105)漲8.37% 24版醫保目錄新增創新藥數量創新高

宜明昂科-B盤中異動股價大漲5.12%報6.370港元

宜明昂科－Ｂ(01541)股價上升8.272%，現價港幣$5.89

阿斯达克财经

港股異動 | 宜明昂科-B(01541)午後漲超5% IMM0306獲批准進行狼瘡性腎炎治療的II期臨牀試驗

宜明昂科-B盤中異動下午盤急速上漲5.15%報5.720港元

宜明昂科-B(01541)上漲5.15%，報5.72元/股

宜明昂科-B12月04日遭主力拋售478萬元環比增加227.40%

股市播報｜A股全線下跌，創業板指跌1.34%，近4400只個股下跌

港股生物醫藥股集體走低，宜明昂科-B跌超6%

老虎资讯综合

宜明昂科-B(01541)下跌5.07%，報5.62元/股

宜明昂科－Ｂ(01541)股價下跌5.068%，現價港幣$5.62

阿斯达克财经

南向資金12月2日淨買入宜明昂科-B341.04萬股連續7日增持

宜明昂科(01541.HK)治療狼瘡性腎炎藥獲國家藥監局批准臨牀試驗

阿斯达克财经

宜明昂科-B：IMM0306獲國家藥監局批准進行狼瘡性腎炎治療的II期臨牀試驗

格隆汇资讯

宜明昂科-B(01541)：IMM0306獲國家藥監局批准進行狼瘡性腎炎治療的II期臨牀試驗

宜明昂科-B(01541)下跌5.26%，報5.76元/股

宜明昂科-B盤中異動股價大漲5.92%

宜明昂科成功配售3315萬股融資約2.3億港元

宜明昂科-B(01541)完成配售合共3315萬股淨籌約2.3億港元

宜明昂科-B(01541)下跌5.65%，報6.68元/股

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/01541/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01541","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"宜明昂科-B","latestPrice":7,"timestamp":1747296514028,"preClose":7.02,"halted":0,"volume":3387600,"delay":0,"floatShares":382000000,"shares":407000000,"eps":-0.9069851614925257,"marketStatus":"已收盤","change":-0.02,"latestTime":"05-15 16:08:34","open":7.3,"high":7.37,"low":6.91,"amount":24145574,"amplitude":0.065527,"askPrice":7.02,"askSize":19000,"bidPrice":7,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-0.9069851614925257,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1747359000000},"marketStatusCode":5,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":7.02,"openAndCloseTimeList":[[1747272600000,1747281600000],[1747285200000,1747296000000]],"volumeRatio":1.063704,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01541\",,,,,undefined,":{"symbol":"01541","floatShares":382000000,"roa":"-21.43%","roe":"-44.38%","lyrEps":-0.906985,"volumeRatio":1.063704,"shares":407000000,"dividePrice":0,"high":7.37,"amplitude":0.065527,"preClose":7.02,"low":6.91,"week52Low":3.21,"pbRate":"3.87","psRate":"33.07","week52High":22,"institutionHeld":0,"latestPrice":7,"committee":-0.938776,"eps":-0.9069851614925257,"divideRate":0,"volume":3387600,"delay":0,"ttmEps":-0.9069851614925257,"open":7.3,"prevYearClose":5.16,"prevWeekClose":6.44,"prevMonthClose":6.25,"prevQuarterClose":5.84,"fiveDayClose":6.39,"twentyDayClose":5.22,"sixtyDayClose":5.52},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01541\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2489425384","title":"醫藥股多數走高 來凱醫藥(02105)漲8.37% 24版醫保目錄新增創新藥數量創新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2489425384","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489425384?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 10:16","pubTimestamp":1733451405,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股多数走高，来凯医药 涨8.37%，宜明昂科涨6.11%，药明康德涨4.8%，药明生物涨3.04%，云顶新耀涨1.43%。中信建投研报表示，24版医保目录总体情况，结果稳定，符合预期。国产药品占比显著提升，新增创新药数量创新高，体现对基金安全、民众医疗需求及支持创新的多方平衡。中成药纳入数量稳定提升，中药饮片数量保持稳定。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1949112","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002562.SGD","BK1515","LU0823426308.USD","01541","LU0708995583.HKD","BK1576","02269","LU1880383366.USD","LU0516423174.USD","BK1161","LU0456846285.SGD","LU0516422366.SGD","LU0359202008.SGD","BK1521","LU0856984785.SGD","BK1610","LU0417516902.SGD","LU0348825331.USD","LU1242518857.USD","LU0588546209.SGD","LU0052750758.USD","LU0359201612.USD","LU1794554557.SGD","LU0516423091.SGD","LU2045819591.USD","LU0043850808.USD","LU2242644610.SGD","LU0516422440.USD","LU1688375341.USD","LU0181495838.USD","SG9999002463.SGD","02359","LU0039217434.USD","LU0572944931.SGD","06978","LU2125910500.SGD","01952","LU0320764599.SGD","LU0326950275.SGD","159992","02105","LU0307460666.USD","BK1574","159938","LU1720050803.USD","IE00B0JY6N72.USD","LU0348735423.USD","LU0327786744.USD","LU1046422090.SGD","09939"],"gpt_icon":0},{"id":"2489440187","title":"宜明昂科-B盤中異動 股價大漲5.12%報6.370港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489440187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489440187?lang=zh_tw&edition=fundamental","pubTime":"2024-12-06 09:41","pubTimestamp":1733449285,"startTime":"0","endTime":"0","summary":"2024年12月06日早盘09时41分，宜明昂科-B股票出现波动，股价快速上涨5.12%。截至发稿，该股报6.370港元/股，成交量316.08万股，换手率0.83%，振幅6.11%。资金方面，该股资金流入937.825万港元，流出430.836万港元。宜明昂科-B股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，巨子生物、北海康成-B、永泰生物-B涨幅较大，振幅较大的相关个股有晶泰科技、宜明昂科-B、来凯医药-B，振幅分别为7.19%、6.11%、5.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206094125971bfd02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206094125971bfd02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2489488325","title":"宜明昂科－Ｂ(01541)股價上升8.272%，現價港幣$5.89","url":"https://stock-news.laohu8.com/highlight/detail?id=2489488325","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489488325?lang=zh_tw&edition=fundamental","pubTime":"2024-12-05 14:30","pubTimestamp":1733380200,"startTime":"0","endTime":"0","summary":"[上升股]宜明昂科－Ｂ(01541) 股价在下午02:30比前收市价上升8.272%，现股价为港币$5.89。至目前为止，今日最高价为$5.89，而最低价为$5.38。总成交量为1.714千万股，总成交金额为港币$9.634千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2412051435/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2489554102","title":"港股異動 | 宜明昂科-B(01541)午後漲超5% IMM0306獲批准進行狼瘡性腎炎治療的II期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2489554102","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489554102?lang=zh_tw&edition=fundamental","pubTime":"2024-12-05 13:40","pubTimestamp":1733377231,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，宜明昂科-B(01541)午后涨超5%，截至发稿，涨3.13%，报5.61港元，成交额6643.18万港元。消息面上，宜明昂科近日发布公告，宣布公司已获中国国家药监局批准进行IMM0306用于治疗狼疮性肾炎的II期临床试验。IMM0306是一种靶向CD47和CD20的双特异性抗体，具有全球首个进入临床阶段的CD47和CD20双靶向特性。据悉，IMM0306是全球首个进入临床阶段的CD47和CD20双靶向双特异性分子，公司拥有其全球知识产权及商业化权利。太平洋证券研报预测，IMM0306远期销售峰值有望达到10.8亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1220707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","03347","01541","BK1161","BK1141","BK1583"],"gpt_icon":0},{"id":"2489710273","title":"宜明昂科-B盤中異動 下午盤急速上漲5.15%報5.720港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489710273","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489710273?lang=zh_tw&edition=fundamental","pubTime":"2024-12-05 13:20","pubTimestamp":1733376025,"startTime":"0","endTime":"0","summary":"2024年12月05日下午盘13时20分，宜明昂科-B股票出现异动，股价快速拉升5.15%。截至发稿，该股报5.720港元/股，成交量899.24万股，换手率2.35%，振幅6.25%。资金方面，该股资金流入1678.23万港元，流出2312.87万港元。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。宜明昂科-B股票所在的生物技术行业中，整体跌幅为0.92%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120513202698e584ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120513202698e584ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2489107328","title":"宜明昂科-B(01541)上漲5.15%，報5.72元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489107328","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489107328?lang=zh_tw&edition=fundamental","pubTime":"2024-12-05 13:20","pubTimestamp":1733376025,"startTime":"0","endTime":"0","summary":"12月5日，宜明昂科-B(01541)盘中上涨5.15%，截至13:20，报5.72元/股，成交4954.02万元。宜明昂科生物医药技术(上海)股份有限公司是一家以科研为导向的生物技术公司，主要致力于开发肿瘤免疫疗法，特别是对先天性免疫和适应性免疫进行系统性利用。该公司曾获得多项荣誉，包括“第二届生物科技创新50企业榜单”、“药物创新济世奖”、“2021中国医药创新种子企业100强”等。截至2024年中报，宜明昂科-B营业总收入7.7万元、净利润-1.66亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/05132046043870.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2488159389","title":"宜明昂科-B12月04日遭主力拋售478萬元 環比增加227.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488159389","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488159389?lang=zh_tw&edition=fundamental","pubTime":"2024-12-04 16:16","pubTimestamp":1733300187,"startTime":"0","endTime":"0","summary":"12月04日, 宜明昂科-B股价跌8.11%，报收5.44元，成交金额7227万元，换手率3.43%，振幅9.46%，量比1.38。宜明昂科-B今日主力资金净流出478万元，上一交易日主力净流出146万元，今日环比增加227.40%。该股近5个交易日下跌23.31%，主力资金累计净流出516万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出596万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204161653abf500c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204161653abf500c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2488134068","title":"股市播報｜A股全線下跌，創業板指跌1.34%，近4400只個股下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2488134068","media":"腾讯财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488134068?lang=zh_tw&edition=fundamental","pubTime":"2024-12-04 14:39","pubTimestamp":1733294367,"startTime":"0","endTime":"0","summary":"09:00 富时中国A50指数期货开跌0.2%      富时中国A50指数期货在上一交易日夜盘收跌0.16%的基础上低开，现跌0.2%。      ","market":"us","thumbnail":"https://inews.gtimg.com/news_ls/OS2OZ4kVzxwLdMtjz_jdA3In4qTAeMU9kR0cj2d-trFY4AA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/news_ls/OS2OZ4kVzxwLdMtjz_jdA3In4qTAeMU9kR0cj2d-trFY4AA_294195/0"],"rights":{"source":"tencent_tech","url":"https://view.inews.qq.com/a/20241204A01MIJ00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://view.inews.qq.com/a/20241204A01MIJ00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK4506","LU0588546209.SGD","MCHmain","LU0052750758.USD","513600","BK1574","LU1969619763.USD","LU2242644610.SGD","LU0307460666.USD","LU2488822045.USD","01541","BK4505","BK1589","09901","LU0370786039.SGD","BK1109","BK1163","IE00B5MMRT66.SGD","LU0572944931.SGD","IE0034224299.USD","02105","BK1583","LU0348783233.USD","09660","LU0823426480.USD","IE00BPRC5H50.USD","LU0320764599.SGD","LU0348784397.USD","01347","09926","LU1720050803.USD","HSI","HHImain","BK1526","LU0048580855.USD","YANG","LU1794554557.SGD","EDU","LU0039217434.USD","BK4510","HSTECH","LU0708995583.HKD","BK1519","09995","LU0502904849.HKD","HSCEI","SG9999006597.SGD","02833"],"gpt_icon":1},{"id":"1153799119","title":"港股生物醫藥股集體走低，宜明昂科-B跌超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1153799119","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153799119?lang=zh_tw&edition=fundamental","pubTime":"2024-12-04 09:57","pubTimestamp":1733277442,"startTime":"0","endTime":"0","summary":"12月4日，港股生物医药股集体走低，$宜明昂科-B(01541)$跌超6%，$康方生物(09926)$跌超5%，$荣昌生物(0995)$、$来凯医药-B(02105)$跌超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YANG","HSCEI","01541","HSTECH","BK1161","399441","161726","07226"],"gpt_icon":0},{"id":"2488188255","title":"宜明昂科-B(01541)下跌5.07%，報5.62元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488188255","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488188255?lang=zh_tw&edition=fundamental","pubTime":"2024-12-04 09:50","pubTimestamp":1733277044,"startTime":"0","endTime":"0","summary":"12月4日，宜明昂科-B(01541)盘中下跌5.07%，截至09:50，报5.62元/股，成交1257.91万元。宜明昂科生物医药技术(上海)股份有限公司是一家以科研为导向的生物技术公司，主要致力于开发肿瘤免疫疗法，特别是对先天性免疫和适应性免疫进行系统性利用。该公司曾获得多项荣誉，包括“第二届生物科技创新50企业榜单”、“药物创新济世奖”、“2021中国医药创新种子企业100强”等。截至2024年中报，宜明昂科-B营业总收入7.7万元、净利润-1.66亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/04095045987433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2488183520","title":"宜明昂科－Ｂ(01541)股價下跌5.068%，現價港幣$5.62","url":"https://stock-news.laohu8.com/highlight/detail?id=2488183520","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488183520?lang=zh_tw&edition=fundamental","pubTime":"2024-12-04 09:50","pubTimestamp":1733277000,"startTime":"0","endTime":"0","summary":"[下跌股]宜明昂科－Ｂ(01541) 股价在上午09:50比前收市价下跌5.068%，现股价为港币$5.62。至目前为止，今日最高价为$5.92，而最低价为$5.62。总成交量为220.66万股，总成交金额为港币$1.258千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD241204178/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2488939452","title":"南向資金12月2日淨買入宜明昂科-B341.04萬股 連續7日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2488939452","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488939452?lang=zh_tw&edition=fundamental","pubTime":"2024-12-03 09:30","pubTimestamp":1733189411,"startTime":"0","endTime":"0","summary":"12月2日, 南向资金增持宜明昂科-B341.04万股，连续7日增持。截止当日收盘，港股通共持有宜明昂科-B7879.50万股，占流通股20.61%。宜明昂科-B近5个交易日下跌18.86%，港股通累计增持742.02万股；近20个交易日下跌21.36%，港股通累计增持2319.95万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203093130a267df40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203093130a267df40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2488225613","title":"宜明昂科(01541.HK)治療狼瘡性腎炎藥獲國家藥監局批准臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2488225613","media":"阿斯达克财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488225613?lang=zh_tw&edition=fundamental","pubTime":"2024-12-02 08:23","pubTimestamp":1733098980,"startTime":"0","endTime":"0","summary":"宜明昂科-B公布，获中国国家药监局批准进行“IMM0306”用于治疗狼疮性肾炎的II期临床试验。据介绍，相关药物是全球首个进入临床阶段的CD47和CD20双靶向双特异性分子，透过抑制CD47-SIRPα相互作用来阻断“别吃我”讯号，增强Fc-FcyRIIa和Fc-FcyRIIIa相互作用来激活巨噬细胞和NK细胞，并优先结合CD20而非CD47，以有效消除恶性B细胞，同时将毒性降至最低，从而可改善治疗效果。另外，宜明昂科拥有“IMM0306”的全球知识产权及商业化权利。沽空资料截至 2024-11-29 16:25。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230915102623267_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230915102623267_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1400862/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","BK1583","03347","BK1161","BK1576","01541"],"gpt_icon":0},{"id":"2488697755","title":"宜明昂科-B：IMM0306獲國家藥監局批准進行狼瘡性腎炎治療的II期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2488697755","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488697755?lang=zh_tw&edition=fundamental","pubTime":"2024-12-02 06:56","pubTimestamp":1733093796,"startTime":"0","endTime":"0","summary":"格隆汇12月2日丨宜明昂科-B发布公告，集团已获中国国家药品监督管理局批准进行IMM0306用于治疗狼疮性肾炎的II期临床试验。由集团独立研发的IMM0306是一种靶向分化簇47及分化簇20的双特异性分子，是全球首个进入临床阶段的CD47和CD20双靶向双特异性分子。截至本公告日期，集团拥有IMM0306的全球知识产权及商业化权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202065643a2648aad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202065643a2648aad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","BK1583","BK1161","03347","01541","BK1141"],"gpt_icon":0},{"id":"2488978856","title":"宜明昂科-B(01541)：IMM0306獲國家藥監局批准進行狼瘡性腎炎治療的II期臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2488978856","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488978856?lang=zh_tw&edition=fundamental","pubTime":"2024-12-02 06:42","pubTimestamp":1733092922,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B(01541)发布公告，集团已获中华人民共和国国家药品监督管理局批准进行IMM0306(一种靶向CD47xCD20的原创新药双特异性抗体)用于治疗狼疮性肾炎(LN)的II期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1218658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1141","BK1576","BK1583","01541","03347"],"gpt_icon":0},{"id":"2487009213","title":"宜明昂科-B(01541)下跌5.26%，報5.76元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2487009213","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487009213?lang=zh_tw&edition=fundamental","pubTime":"2024-11-29 14:03","pubTimestamp":1732860213,"startTime":"0","endTime":"0","summary":"11月29日，宜明昂科-B(01541)盘中下跌5.26%，截至14:03，报5.76元/股，成交4712.64万元。宜明昂科生物医药技术(上海)股份有限公司是一家以科研为导向的生物技术公司，主要致力于开发肿瘤免疫疗法，特别是对先天性免疫和适应性免疫进行系统性利用。该公司曾获得多项荣誉，包括“第二届生物科技创新50企业榜单”、“药物创新济世奖”、“2021中国医药创新种子企业100强”等。截至2024年中报，宜明昂科-B营业总收入7.7万元、净利润-1.66亿元。11月28日，完成配售3315万新股份，占扩大后股本8.14%，每股配售价7.05港元，净筹2.297亿港元(实施)。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/29140345832670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2487376421","title":"宜明昂科-B盤中異動 股價大漲5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487376421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487376421?lang=zh_tw&edition=fundamental","pubTime":"2024-11-29 09:30","pubTimestamp":1732843827,"startTime":"0","endTime":"0","summary":"2024年11月29日早盘09时30分，宜明昂科-B股票出现波动，股价急速上涨5.92%。截至发稿，该股报6.440港元/股，成交量40.04万股，换手率0.10%，振幅5.10%。宜明昂科-B股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，宜明昂科-B、云顶新耀-B、乐普生物-B涨幅较大，振幅较大的相关个股有宜明昂科-B、再鼎医药、科笛-B，振幅分别为4.28%、3.17%、2.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112909302798e4525f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112909302798e4525f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2486847394","title":"宜明昂科成功配售3315萬股 融資約2.3億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486847394","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486847394?lang=zh_tw&edition=fundamental","pubTime":"2024-11-28 18:42","pubTimestamp":1732790531,"startTime":"0","endTime":"0","summary":"财中社11月28日电宜明昂科-B（01541）发布公告，宣布根据配售协议的条款，已于2024年11月28日成功交割，完成新H股的配售。此次配售共计3315万股，配售价为每股7.05港元，交割前占公司已发行股本的约8.86%及已发行H股总数的约9.50%。交割后，公司的已发行股份总数由3.74亿股增至4.07亿股，已发行H股总数由3.49亿股增至3.82亿股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411283253876272.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2486396455","title":"宜明昂科-B(01541)完成配售合共3315萬股 淨籌約2.3億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486396455","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486396455?lang=zh_tw&edition=fundamental","pubTime":"2024-11-28 18:15","pubTimestamp":1732788915,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B(01541)发布公告，根据配售协议的条款及条件，配售代理已按每股配售股份7.05港元的配售价成功向不少于六名承配人配售合共3315万股配售股份，于紧接交割前占公司已发行股本数目约8.86%及已发行H股总数约9.50%，以及于紧随交割后站经配发及发行配售股份扩大的公司已发行H股总数约8.67%及已发行股本数目约8.14%。经扣除配售事项佣金及配售事项的其他相关成本及开支后，配售事项所得款项净额约为2.3亿港元，相当于净配售价约每股配售股份6.93港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1217373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2486336110","title":"宜明昂科-B(01541)下跌5.65%，報6.68元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486336110","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486336110?lang=zh_tw&edition=fundamental","pubTime":"2024-11-28 09:43","pubTimestamp":1732758188,"startTime":"0","endTime":"0","summary":"11月28日，宜明昂科-B(01541)盘中下跌5.65%，截至09:43，报6.68元/股，成交733.24万元。宜明昂科生物医药技术(上海)股份有限公司是一家以科研为导向的生物技术公司，主要致力于开发肿瘤免疫疗法，特别是对先天性免疫和适应性免疫进行系统性利用。该公司曾获得多项荣誉，包括“第二届生物科技创新50企业榜单”、“药物创新济世奖”、“2021中国医药创新种子企业100强”等。截至2024年中报，宜明昂科-B营业总收入7.7万元、净利润-1.66亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/28094345780802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","01541"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01541\",params:#limit:5,,,undefined,":[{"date":"2025-03-25","symbol":"01541","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"盤後","dateTimestamp":1742832000000,"actualEps":null},{"market":"HK","date":"2024-08-26","symbol":"01541","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1724601600000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-25","symbol":"01541","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01541\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01541\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1697558400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01541\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01541","date":"2025-05-14","current":-8.354374,"percent":0.580723,"low":-30.003263,"twenty":-24.81013,"median":-12.288977,"eighty":-5.744251,"high":-2.993766,"avg":-13.619318,"sd":8.259894,"marketCap":2859300018},"quantilePoints":[{"date":"2023-08-31","current":-17.746094,"twenty":-17.746094,"median":-17.746094,"eighty":-17.746094,"marketCap":6942262047},{"date":"2023-09-08","current":-19.116691,"twenty":-19.083294,"median":-18.655615,"eighty":-17.801139,"marketCap":7390149921},{"date":"2023-09-15","current":-24.765877,"twenty":-24.765877,"median":-19.116691,"eighty":-18.557812,"marketCap":9648251285},{"date":"2023-09-22","current":-25.548224,"twenty":-25.200205,"median":-24.360534,"eighty":-18.753419,"marketCap":9909519212},{"date":"2023-09-29","current":-29.804324,"twenty":-26.447668,"median":-24.870232,"eighty":-19.083294,"marketCap":11580180660},{"date":"2023-10-06","current":-24.76052,"twenty":-26.458287,"median":-24.870232,"eighty":-19.110012,"marketCap":9615852761},{"date":"2023-10-13","current":-27.113287,"twenty":-26.458287,"median":-25.206314,"eighty":-22.322253,"marketCap":10513831229},{"date":"2023-10-20","current":-26.768577,"twenty":-26.795293,"median":-25.37532,"eighty":-23.788881,"marketCap":10364168151},{"date":"2023-10-27","current":-28.665306,"twenty":-27.124745,"median":-25.753577,"eighty":-24.00727,"marketCap":11093775656},{"date":"2023-11-03","current":-26.275244,"twenty":-27.500238,"median":-26.158488,"eighty":-24.473108,"marketCap":10195797188},{"date":"2023-11-10","current":-26.039628,"twenty":-27.37617,"median":-26.041732,"eighty":-24.763734,"marketCap":10102257765},{"date":"2023-11-17","current":-26.714897,"twenty":-27.225983,"median":-26.171076,"eighty":-24.792429,"marketCap":10457707575},{"date":"2023-11-24","current":-27.539565,"twenty":-27.37617,"median":-26.271304,"eighty":-24.846191,"marketCap":10869281039},{"date":"2023-12-01","current":-28.464343,"twenty":-27.564693,"median":-26.306056,"eighty":-24.874164,"marketCap":11280854504},{"date":"2023-12-08","current":-27.67933,"twenty":-27.70336,"median":-26.447668,"eighty":-25.070837,"marketCap":10925404694},{"date":"2023-12-15","current":-27.708906,"twenty":-27.817253,"median":-26.526325,"eighty":-25.207536,"marketCap":11000236233},{"date":"2023-12-22","current":-27.916049,"twenty":-27.937914,"median":-26.714897,"eighty":-25.244891,"marketCap":11075067772},{"date":"2023-12-29","current":-28.049426,"twenty":-27.986303,"median":-26.835368,"eighty":-25.288293,"marketCap":11187315080},{"date":"2024-01-05","current":-23.146888,"twenty":-27.970711,"median":-26.68937,"eighty":-25.200205,"marketCap":9166863527},{"date":"2024-01-12","current":-26.439512,"twenty":-27.935571,"median":-26.500765,"eighty":-25.200205,"marketCap":10476415460},{"date":"2024-01-19","current":-25.435754,"twenty":-27.916049,"median":-26.490281,"eighty":-25.212424,"marketCap":10064841995},{"date":"2024-01-26","current":-23.636611,"twenty":-27.83997,"median":-26.442842,"eighty":-24.972615,"marketCap":9316526605},{"date":"2024-02-02","current":-21.195554,"twenty":-27.817533,"median":-26.372788,"eighty":-24.783518,"marketCap":8343716598},{"date":"2024-02-09","current":-18.727145,"twenty":-27.802108,"median":-26.275244,"eighty":-24.041989,"marketCap":7408322361},{"date":"2024-02-16","current":-17.739662,"twenty":-27.801452,"median":-26.252628,"eighty":-23.794995,"marketCap":7019198358},{"date":"2024-02-23","current":-22.387155,"twenty":-27.764049,"median":-26.165159,"eighty":-23.13759,"marketCap":8811413717},{"date":"2024-03-01","current":-17.708555,"twenty":-27.735275,"median":-26.04068,"eighty":-22.460898,"marketCap":6974299434},{"date":"2024-03-08","current":-19.229551,"twenty":-27.718352,"median":-26.025076,"eighty":-21.141323,"marketCap":7576693323},{"date":"2024-03-15","current":-16.157629,"twenty":-27.69116,"median":-25.695795,"eighty":-19.998834,"marketCap":6360680815},{"date":"2024-03-22","current":-15.411367,"twenty":-27.66021,"median":-25.548224,"eighty":-19.057216,"marketCap":6061354659},{"date":"2024-03-28","current":-14.696214,"twenty":-27.629432,"median":-25.408294,"eighty":-18.737655,"marketCap":6038905197},{"date":"2024-04-05","current":-13.011166,"twenty":-27.602384,"median":-25.364375,"eighty":-18.557812,"marketCap":5342971884},{"date":"2024-04-12","current":-13.094845,"twenty":-27.539565,"median":-25.225009,"eighty":-18.239836,"marketCap":5380387654},{"date":"2024-04-19","current":-13.014894,"twenty":-27.51439,"median":-25.154554,"eighty":-17.708555,"marketCap":5342971884},{"date":"2024-04-26","current":-13.779237,"twenty":-27.443648,"median":-24.972615,"eighty":-16.602696,"marketCap":5649781194},{"date":"2024-05-03","current":-12.839078,"twenty":-27.434442,"median":-24.870232,"eighty":-16.184677,"marketCap":5260657191},{"date":"2024-05-10","current":-13.282389,"twenty":-27.357513,"median":-24.774698,"eighty":-14.702373,"marketCap":5455219193},{"date":"2024-05-17","current":-13.228926,"twenty":-27.225983,"median":-24.581805,"eighty":-14.243189,"marketCap":5425286577},{"date":"2024-05-24","current":-13.350651,"twenty":-27.145452,"median":-23.955191,"eighty":-13.966896,"marketCap":5462702347},{"date":"2024-05-31","current":-13.410156,"twenty":-27.124745,"median":-23.750163,"eighty":-13.747349,"marketCap":5492634962},{"date":"2024-06-07","current":-14.158514,"twenty":-27.039336,"median":-23.288627,"eighty":-13.645876,"marketCap":5791961118},{"date":"2024-06-14","current":-13.347574,"twenty":-26.971042,"median":-23.123643,"eighty":-13.527845,"marketCap":5455219193},{"date":"2024-06-21","current":-13.283836,"twenty":-26.926395,"median":-22.448608,"eighty":-13.452996,"marketCap":5417803423},{"date":"2024-06-28","current":-12.683619,"twenty":-26.848726,"median":-21.974147,"eighty":-13.40419,"marketCap":5170859344},{"date":"2024-07-05","current":-11.291057,"twenty":-26.759122,"median":-21.059976,"eighty":-13.359292,"marketCap":4602139648},{"date":"2024-07-12","current":-12.246119,"twenty":-26.720023,"median":-20.206581,"eighty":-13.323498,"marketCap":4998746805},{"date":"2024-07-19","current":-11.915911,"twenty":-26.704686,"median":-19.229551,"eighty":-13.282563,"marketCap":4864050035},{"date":"2024-07-26","current":-11.780484,"twenty":-26.652155,"median":-19.050696,"eighty":-13.224977,"marketCap":4826634265},{"date":"2024-08-02","current":-13.633124,"twenty":-26.594701,"median":-18.753419,"eighty":-13.20236,"marketCap":5582432809},{"date":"2024-08-09","current":-9.567144,"twenty":-26.54166,"median":-18.630761,"eighty":-13.102374,"marketCap":3943622105},{"date":"2024-08-16","current":-8.483685,"twenty":-26.496571,"median":-18.451463,"eighty":-13.086665,"marketCap":3498374448},{"date":"2024-08-23","current":-8.095604,"twenty":-26.47337,"median":-18.020488,"eighty":-13.035717,"marketCap":3352452947},{"date":"2024-08-30","current":-7.377309,"twenty":-26.446703,"median":-17.739662,"eighty":-12.990136,"marketCap":3034418906},{"date":"2024-09-06","current":-4.227864,"twenty":-26.442176,"median":-17.681919,"eighty":-12.840212,"marketCap":1739833281},{"date":"2024-09-13","current":-4.503325,"twenty":-26.43833,"median":-16.602696,"eighty":-12.741292,"marketCap":1848339013},{"date":"2024-09-20","current":-4.539912,"twenty":-26.433601,"median":-16.202037,"eighty":-12.246119,"marketCap":1874530051},{"date":"2024-09-27","current":-5.476578,"twenty":-26.311976,"median":-15.844451,"eighty":-11.915911,"marketCap":2274878785},{"date":"2024-10-04","current":-6.596451,"twenty":-26.302504,"median":-15.05764,"eighty":-11.832338,"marketCap":2727609596},{"date":"2024-10-10","current":-5.983695,"twenty":-26.285201,"median":-14.496802,"eighty":-11.807116,"marketCap":2458216056},{"date":"2024-10-18","current":-5.191078,"twenty":-26.27288,"median":-14.209972,"eighty":-11.719903,"marketCap":2121474130},{"date":"2024-10-25","current":-7.104995,"twenty":-26.248892,"median":-14.119017,"eighty":-11.287262,"marketCap":2903463713},{"date":"2024-11-01","current":-6.615271,"twenty":-26.199776,"median":-13.881638,"eighty":-9.764235,"marketCap":2705160134},{"date":"2024-11-08","current":-6.847628,"twenty":-26.169892,"median":-13.803075,"eighty":-8.441853,"marketCap":2787474827},{"date":"2024-11-15","current":-7.078843,"twenty":-26.118271,"median":-13.690467,"eighty":-8.248986,"marketCap":2851081635},{"date":"2024-11-22","current":-6.784782,"twenty":-26.059844,"median":-13.633178,"eighty":-7.853303,"marketCap":2731351173},{"date":"2024-11-29","current":-5.682581,"twenty":-26.04047,"median":-13.539989,"eighty":-7.45767,"marketCap":2286103516},{"date":"2024-12-06","current":-5.602773,"twenty":-26.037499,"median":-13.514674,"eighty":-7.358253,"marketCap":2248687746},{"date":"2024-12-13","current":-6.121403,"twenty":-26.029477,"median":-13.45004,"eighty":-7.218028,"marketCap":2451992323},{"date":"2024-12-20","current":-5.137492,"twenty":-25.962318,"median":-13.411134,"eighty":-7.087735,"marketCap":2048757705},{"date":"2024-12-27","current":-4.957491,"twenty":-25.887099,"median":-13.400213,"eighty":-7.078006,"marketCap":1975442320},{"date":"2025-01-03","current":-5.238569,"twenty":-25.753577,"median":-13.368079,"eighty":-6.925822,"marketCap":2089488475},{"date":"2025-01-10","current":-5.002231,"twenty":-25.638014,"median":-13.3526,"eighty":-6.765934,"marketCap":1987661551},{"date":"2025-01-17","current":-5.018682,"twenty":-25.5579,"median":-13.317479,"eighty":-6.665777,"marketCap":1995807705},{"date":"2025-01-24","current":-5.323319,"twenty":-25.548224,"median":-13.283546,"eighty":-6.596451,"marketCap":2130219244},{"date":"2025-01-28","current":-5.224689,"twenty":-25.503236,"median":-13.282823,"eighty":-6.532117,"marketCap":2101707706},{"date":"2025-02-07","current":-5.549725,"twenty":-25.42477,"median":-13.246663,"eighty":-6.254752,"marketCap":2219826937},{"date":"2025-02-14","current":-5.930475,"twenty":-25.395104,"median":-13.220128,"eighty":-6.076947,"marketCap":2366457707},{"date":"2025-02-21","current":-6.375256,"twenty":-25.366564,"median":-13.201126,"eighty":-6.054191,"marketCap":2557892324},{"date":"2025-02-28","current":-5.632443,"twenty":-25.318672,"median":-13.116805,"eighty":-5.974648,"marketCap":2252411553},{"date":"2025-03-07","current":-5.782376,"twenty":-25.249925,"median":-13.099044,"eighty":-5.827424,"marketCap":2321653861},{"date":"2025-03-14","current":-4.421401,"twenty":-25.219975,"median":-13.087912,"eighty":-5.725677,"marketCap":1775861550},{"date":"2025-03-21","current":-4.778207,"twenty":-25.207536,"median":-13.071662,"eighty":-5.66584,"marketCap":1918419243},{"date":"2025-03-28","current":-6.735516,"twenty":-25.163684,"median":-13.026305,"eighty":-5.651503,"marketCap":2276850015},{"date":"2025-04-03","current":-7.956153,"twenty":-25.0977,"median":-13.01303,"eighty":-5.66026,"marketCap":2684157710},{"date":"2025-04-11","current":-6.344288,"twenty":-25.036833,"median":-12.972072,"eighty":-5.68428,"marketCap":2126146167},{"date":"2025-04-17","current":-6.122985,"twenty":-24.972615,"median":-12.844749,"eighty":-5.691075,"marketCap":2056903859},{"date":"2025-04-25","current":-8.576896,"twenty":-24.895951,"median":-12.836736,"eighty":-5.703559,"marketCap":2883738480},{"date":"2025-05-02","current":-7.700417,"twenty":-24.872853,"median":-12.82514,"eighty":-5.710649,"marketCap":2594550017},{"date":"2025-05-09","current":-7.730765,"twenty":-24.846191,"median":-12.683619,"eighty":-5.725677,"marketCap":2623061555},{"date":"2025-05-14","current":-8.354374,"twenty":-24.81013,"median":-12.288977,"eighty":-5.744251,"marketCap":2859300018}],"updateTime":1747314485371}}}